Featured Research

from universities, journals, and other organizations

Novel Drug Therapy For Sleep Apnea

Date:
October 5, 2004
Source:
University Of Illinois At Chicago
Summary:
A promising drug therapy for the treatment of sleep apnea, a serious and common sleep-related breathing disorder has been licensed by the University of Illinois at Chicago, where it was first conceptualized, to an intellectual property and technology commercialization company for clinical development.

A promising drug therapy for the treatment of sleep apnea, a serious and common sleep-related breathing disorder has been licensed by the University of Illinois at Chicago, where it was first conceptualized, to an intellectual property and technology commercialization company for clinical development.

Related Articles


UIC signed a licensing and research agreement to further develop a novel pharmacological therapy for sleep apnea with BTG, of Conshohocken, Pa.

The basis for the therapy was uncovered by two noted UIC sleep researchers, Drs. David Carley and Miodrag Radulovacki, who demonstrated in preclinical and clinical studies that turning up or down the signaling pathways of certain neurotransmitters can significantly reduce the incidence of sleep apnea.

"This has real clinical significance," said Carley, who is professor of medicine, pharmacology and bioengineering and director of research at the UIC Center for Sleep and Ventilatory Disorders. "Although sleep apnea is as common as asthma or diabetes, there is currently no cure and no fully effective long-term treatment."

Sleep apnea is a serious respiratory disorder that involves cessation of breathing for prolonged intervals during sleep. It is estimated that 15-20 million people in the United States suffer from apnea, which has been linked to increased risk for hypertension, heart failure, depression and diabetes.

Currently, no drugs are approved to treat sleep apnea. The novel therapy being developed by BTG and UIC comprises a combination of two drugs that are currently approved and in use to treat conditions unrelated to sleep apnea.

"We believe that safe and effective drug treatments are achievable for sleep apnea, and are delighted to have BTG as a strategic partner in this development program," said Radulovacki, who is professor of pharmacology and medicine.

Under the terms of the agreement, UIC grants BTG specific exclusive rights to intellectual property and inventions related to the development of therapeutic treatment of sleep apnea, as well as rights to new intellectual property developed through a BTG funded research program. The agreement also includes a revenue share arrangement between the parties upon successful product commercialization.

"BTG is very proud to be working with UIC and investigators of Drs. Carley and Radulovacki's stature," said Thomas Logan, vice president of BTG's BioPharmaceuticals business unit. "Based on their groundbreaking laboratory and clinical research we are optimistic that a pharmacological therapeutic option to treat sleep apnea is achievable.

"This investment project is a continuation of a very productive relationship between our institutions and is a lead program in BTG's portfolio of clinical development programs that involve new uses for existing drugs and drug combinations," Logan said.

UIC ranks among the nation's top 50 universities in federal research funding and is Chicago's largest university with 25,000 students, 12,000 faculty and staff, 15 colleges and the state's major public medical center. A hallmark of the campus is the Great Cities Commitment, through which UIC faculty, students and staff engage with community, corporate, foundation and government partners in hundreds of programs to improve the quality of life in metropolitan areas around the world.


Story Source:

The above story is based on materials provided by University Of Illinois At Chicago. Note: Materials may be edited for content and length.


Cite This Page:

University Of Illinois At Chicago. "Novel Drug Therapy For Sleep Apnea." ScienceDaily. ScienceDaily, 5 October 2004. <www.sciencedaily.com/releases/2004/10/041005073612.htm>.
University Of Illinois At Chicago. (2004, October 5). Novel Drug Therapy For Sleep Apnea. ScienceDaily. Retrieved March 30, 2015 from www.sciencedaily.com/releases/2004/10/041005073612.htm
University Of Illinois At Chicago. "Novel Drug Therapy For Sleep Apnea." ScienceDaily. www.sciencedaily.com/releases/2004/10/041005073612.htm (accessed March 30, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, March 30, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Soda, Salt and Sugar: The Next Generation of Taxes

Soda, Salt and Sugar: The Next Generation of Taxes

Washington Post (Mar. 30, 2015) — Denisa Livingston, a health advocate for the Dinι Community Advocacy Alliance, and the Post&apos;s Abby Phillip discuss efforts around the country to make unhealthy food choices hurt your wallet as much as your waistline. Video provided by Washington Post
Powered by NewsLook.com
UnitedHealth Buys Catamaran

UnitedHealth Buys Catamaran

Reuters - Business Video Online (Mar. 30, 2015) — The $12.8 billion merger will combine the U.S.&apos; third and fourth largest pharmacy benefit managers. Analysts say smaller PBMs could also merge. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) — A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins